indocyanine green has been researched along with Klatskin Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, C; Li, W; Liu, G; Lv, P; Mao, J; Wang, X; Zhang, P; Zhang, X; Zhang, Y | 1 |
| Li, M; Liu, H; Ni, X; Shen, F; Song, J; Song, L; Suo, T; Wang, J; Zhong, M | 1 |
1 trial(s) available for indocyanine green and Klatskin Tumor
| Article | Year |
|---|---|
Preoperative ICG Test to Predict Posthepatectomy Liver Failure and Postoperative Outcomes in Hilar Cholangiocarcinoma.
Topics: Adult; Aged; Aged, 80 and over; Bile Duct Neoplasms; Female; Humans; Indocyanine Green; Klatskin Tumor; Liver Failure; Male; Middle Aged; Postoperative Complications; Preoperative Care | 2021 |
1 other study(ies) available for indocyanine green and Klatskin Tumor
| Article | Year |
|---|---|
Bio-engineered cell membrane nanovesicles as precision theranostics for perihilar cholangiocarcinoma.
Topics: Animals; Bile Duct Neoplasms; Cell Line, Tumor; HEK293 Cells; Humans; Hyperthermia, Induced; Indocyanine Green; Klatskin Tumor; Mice; Nanoparticles; Neoplasm Transplantation; Photoacoustic Techniques; Precision Medicine; Receptor, ErbB-2; Recombinant Fusion Proteins; Theranostic Nanomedicine; Treatment Outcome; Xenograft Model Antitumor Assays | 2020 |